Digitalization And Health Focus Will Expand Global Reach

Published
07 Nov 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
€44.41
6.8% undervalued intrinsic discount
07 Aug
€41.39
Loading
1Y
27.9%
7D
3.5%

Author's Valuation

€44.4

6.8% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 3.97%

Shared on23 Apr 25
Fair value Increased 0.26%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget has decreased revenue growth from 10.8% to 8.4%.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 1.77%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 7.92%

AnalystConsensusTarget has decreased revenue growth from 14.7% to 10.6% and increased discount rate from 5.8% to 6.8%.

Shared on19 Mar 25
Fair value Increased 0.066%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 3.16%

AnalystConsensusTarget has increased revenue growth from 8.5% to 14.7%, decreased future PE multiple from 13.0x to 11.5x, decreased discount rate from 6.6% to 5.8% and decreased shares outstanding growth rate from -0.0% to -0.0%.